Skip to main content
. 2017 Dec 10;2017:1397902. doi: 10.1155/2017/1397902

Figure 3.

Figure 3

Sanger sequencing results (reverse complement) of PCR products including UGT1A1∗28 A(TA)6/7TAA and UGT1A1∗6 G>A. (a) Sequencing by the primer SP6. (b) Sequencing by the primer SP7. (c) and (d) were two haplotypes obtained from TA cloning and Sanger sequencing. The arrows indicated the loci tested.

HHS Vulnerability Disclosure